Oslo Bio Update May 2009 - Neuroscience special

A newsletter from Oslo Teknopol covering activities in the life science cluster in the Oslo region.


Nobel Prize winner Peter Agre's backs Nansen Neuroscience Network launch.
Norwegian biotech stocks storm ahead despite credit crunch.

Oslo Cancer Cluster  "Young leader" Reve to promote cancer treatment in Africa.
World's first Alzheimer's blood test developers DiaGenic profiled.

pHealth2009 in June focus on Wearable Micro and Nanosystems for Personalised Health.

….and much more.

Oslo Stock Exchange. Photo: John Hughes
Oslo Stock Exchange. Photo: John Hughes

Oslo biotech stocks weather the storm

Despite the credit crunch, biotech stocks on the Oslo stock market have performed surprisingly well. Algeta has led the way following a successful fundraising at 1,7 USD at the turn of year and by the beginning of May they had more than doubled to 3,6 USD. Other rises included Clavis up 11.1 %, Biotech Pharmacon +69 %, and PhotoCure +49.1 %.

Peter Agre. Photo: John Hopkins, Malaria Research Institute.
Peter Agre. Photo: John Hopkins, Malaria Research Institute.

A modest master

Viewpoint
Peter Agre is the President of the American Association for the Advancement for Science (AAAS) and currently heads up the Malaria Research Institute at Johns Hopkins University in Baltimore, Maryland. He was awarded a Nobel Prize for his discovery of aquaporins, the long sought after water channel proteins, in 1991. His discovery, as well as his Norwegian heritage, has led him into a longstanding collaboration with aquaporins researchers at Oslo’s centre for excellence in neuroscience.

Photo: Norwegian Polar Institute
Photo: Norwegian Polar Institute

Nansen Neuroscience Network launched

BIO2009 Parade
The famous Norwegian explorer, humanitarian and diplomat Nansen (1861-1930) also pioneered routes the mind and is the inspiration behind the new Nansen Neuroscience Network exhibiting at BIO2009 in Atlanta.

Photo: iStockphoto
Photo: iStockphoto

“Young Global Leader” Reve to promote cancer treatment in Africa

Oslo Cancer Cluster CEO Bjarte Reve (36) is one of 200 Young Global Leaders appointed by the World Economic Forum in 2009. Reve intends to use his nomination to promote the development of better cancer diagnostics and treatments in Africa.

Photo: DiaGenic
Photo: DiaGenic

Taking gene expression testing mainstream

DiaGenic - Company Profile

The development of microarray technology has raised expectations for a new generation of both predictive and diagnostic tests able to measure complex combinations of biochemical and genetic markers. 

Photo: MI Lab in Trondheim
Photo: MI Lab in Trondheim

From imagining to imaging

Along with the CMBN in Oslo, the other main axis of the new Nansen Neuroscience Network is the MI Lab in Trondheim, a Norwegian Centre for Research Based Innovation. MI Lab pioneers a more intelligent approach to neuroimaging.


BerGenBio joins growing RNA cluster

One to Watch - BerGenBio

RNA continues to be one of the hottest topics in drug discovery and a mini-cluster of companies is appearing in Norway. Following PCI-Biotech and siRNAsense, the latest entrant is BerGenBio.

Photo: Event
Photo: Event

Creating the best technology for health!

Event Calendar
Oslo is host for the 6th international workshop on Wearable Micro and Nanosystems for Personalised Health in June. Spectacular technology demonstration events and outstanding speakers…

Contact

Shortcut to Oslo Teknopol employees according to specialty

Your guide

Useful links arranged by subject

Newsletter

List of newsletters from Oslo Teknopol